GSK plc (NYSE: GSK) announced headline
Senator’s Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company’s Q3 Results That Set Stock Slide In Motion
November 17, 3:02 AM
Sen. Tommy Tuberville bought 3 tranches of put options to sell Tesla shares at $190 a day ahead of Q3 results that set in motion a stock slump.
November 16, 7:58 AM
Sanofi SA (NYSE: SNY) has reportedly initiated talks with Rothschild & Co. to explore the possibility of spinning off its consumer health division, which could potentially value the business at over $20 billion.
November 15, 9:15 AM
Biotech company Acuitas Therapeutics has filed a lawsuit in Virginia federal court against Germany-based CureVac SE (NASDAQ: CVAC), accusing it of failing to credit Acuitas on patents related to COVID-19 vaccines.
GSK Plc Announces The CHMP Of The EMA Has Adopted A Positive Opinion Recommending Approval Of Momelotinib For The Treatment Of Disease-related Splenomegaly Or Symptoms In Adult Patients With Moderate To Severe Anaemia
November 13, 10:13 AM
GSK plc (NYSE: GSK) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of momelotinib for the treatment of disease-related splenomegaly (enlarged spleen) or symptoms in adult patients with moderate to severe anaemia
CureVac Announces Solid Progress In Phase 2 COVID-19 And Seasonal Flu Clinical Development Programs In Collaboration With GSK
November 1, 8:27 AM
COVID-19 Phase 2 clinical trial fully enrolledStudy compares mono- and bivalent vaccine candidates against licensed comparator COVID-19 vaccineFirst participant dosed in seasonal flu Phase 2 part of combined Phase 1/2